Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model.

Reguraman, Narendran; Hassani, Asma; Philip, Pretty S; Pich, Dagmar; Hammerschmidt, Wolfgang; Khan, Gulfaraz

Reguraman, Narendran; Hassani, Asma; Philip, Pretty S; Pich, Dagmar; Hammerschmidt, Wolfgang; Khan, Gulfaraz.

Afiliación

Reguraman N; Department of Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Hassani A; Department of Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Philip PS; Department of Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Pich D; Research Unit Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, 25, D-81377 Munich, Germany.
Hammerschmidt W; Research Unit Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, 25, D-81377 Munich, Germany.
Khan G; Department of Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.

Vaccines (Basel) ; 11(3)2023 Feb 24.

Article en En | MEDLINE | ID: mdl-36992124

Palabras clave

EBV; VLP; booster dose; immune response; rabbits; vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Emiratos Árabes Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google